Eversheds advises Recordati Spa on the acquisition of shares in Opalia Pharma

Eversheds has advised Recordati Spa, an Italian group of pharmaceutical laboratories, on the acquisition of 67 per cent of shares in Tunisian pharmaceutical company Opalia Pharma.

Milan-based Recordati was advised by Eversheds Paris in collaboration with Eversheds El Heni in Tunisia, with partners Boris Martor, Farès Koussay El Heni, Raouf Mohamed El Heni and Dan Roskis working closely with associates Jawad Fassi-Fehri and Imène Boukadoum.

Further counsel was provided by Anna Buscall of Arnold & Porter.

  • Print

Briefings from Eversheds

  • Market abuse regime

    The current EU market abuse regime is in line for an overhaul. It is anticipated that the implementation of the new proposals may not come into force until 2016.

  • Unfair relationships — what does the future hold?

    The ‘unfair relationship’ concept in respect of credit agreements was introduced into the Consumer Credit Act 1974 on 6 April 2007.

View more briefings from Eversheds

Analysis from The Lawyer

View more analysis from The Lawyer

Overview

1 Wood Street
London
EC2V 7WS
UK
http://www.eversheds.com

Turnover (£m): 376.00
No. of Lawyers: 1,264
No. of Lawyers (Asia Pacific): 68
Offices (Asia Pacific): 3

Jobs

View all jobs from this firm